首页> EMBO molecular medicine> A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond.

A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond.

导出 OA

翻译打印收藏纠错

第一作者： Shiran,Shapira

第一单位： The Health Promotion Center and Integrated Cancer Prevention Center, Tel Aviv, Israel.;Department of Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

作者： Shiran,Shapira ^[1] ; Marina,Ben Shimon ^[2] ; Mori,Hay-Levi ^[2] ; Gil,Shenberg ^[2] ; Guy,Choshen ^[3] ; Lian,Bannon ^[4] ; Michael,Tepper ^[2] ; Dina,Kazanov ^[2] ; Jonathan,Seni ^[1] ; Shahar,Lev-Ari ^[1] ; Michael,Peer ^[5] ; Dimitrios,Boubas ^[6] ; Justin,Stebbing ^[7] ; Sotirios,Tsiodras ^[6] ; Nadir,Arber ^[1]

作者单位： The Health Promotion Center and Integrated Cancer Prevention Center, Tel Aviv, Israel.;Department of Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[1] The Health Promotion Center and Integrated Cancer Prevention Center, Tel Aviv, Israel. ^[2] Department of Internal Medicine H, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. ^[3] Department of Internal Medicine F, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. ^[4] Department of Thoracic Surgery, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. ^[5] 4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece. ^[6] Department of Surgery and Cancer, Imperial College, London, UK. ^[7]

关键词 CD24 COVID-19 EXO-CD24 cytokine storm exosomes

医学主题词动物(Animals);细胞因子类(Cytokines);外泌体(Exosomes);人类(Humans);肺(Lung);小鼠(Mice)

DOI 10.15252/emmm.202215997

PMID 35776000

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交